Venus Concept (VERO) Competitors $0.36 -0.01 (-1.97%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$0.34 -0.02 (-4.88%) As of 09:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VERO vs. BTCY, AEMD, CHEK, ICU, POAI, NURO, CUTR, MHUA, ALUR, and STRRShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Biotricity (BTCY), Aethlon Medical (AEMD), Check-Cap (CHEK), SeaStar Medical (ICU), Predictive Oncology (POAI), NeuroMetrix (NURO), Cutera (CUTR), Meihua International Medical Technologies (MHUA), Allurion Technologies (ALUR), and Star Equity (STRR). These companies are all part of the "medical equipment" industry. Venus Concept vs. Biotricity Aethlon Medical Check-Cap SeaStar Medical Predictive Oncology NeuroMetrix Cutera Meihua International Medical Technologies Allurion Technologies Star Equity Venus Concept (NASDAQ:VERO) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations. Does the media prefer VERO or BTCY? In the previous week, Biotricity had 1 more articles in the media than Venus Concept. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for Venus Concept. Venus Concept's average media sentiment score of 1.00 beat Biotricity's score of 0.00 indicating that Venus Concept is being referred to more favorably in the media. Company Overall Sentiment Venus Concept Positive Biotricity Neutral Which has more risk & volatility, VERO or BTCY? Venus Concept has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Does the MarketBeat Community believe in VERO or BTCY? Venus Concept received 34 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 65.38% of users gave Venus Concept an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformVenus ConceptOutperform Votes3465.38% Underperform Votes1834.62% BiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Which has preferable earnings and valuation, VERO or BTCY? Biotricity has lower revenue, but higher earnings than Venus Concept. Biotricity is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenus Concept$76.35M0.03-$37.25M-$8.02-0.05Biotricity$12.06M0.71-$14.09M-$1.37-0.26 Do institutionals and insiders believe in VERO or BTCY? 87.4% of Venus Concept shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 58.0% of Venus Concept shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend VERO or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Venus Concept 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is VERO or BTCY more profitable? Venus Concept has a net margin of -74.62% compared to Biotricity's net margin of -97.05%. Company Net Margins Return on Equity Return on Assets Venus Concept-74.62% N/A -47.46% Biotricity -97.05%N/A -221.26% SummaryVenus Concept beats Biotricity on 9 of the 15 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.63M$4.71B$5.21B$9.14BDividend YieldN/A47.30%5.13%4.02%P/E Ratio-0.0526.2989.4217.36Price / Sales0.0358.291,240.0477.11Price / CashN/A50.1443.7535.97Price / Book-0.157.795.314.79Net Income-$37.25M$13.87M$122.54M$225.00M7 Day Performance1.28%2.85%1.42%2.37%1 Month Performance12.40%10.48%2.50%4.40%1 Year Performance-72.93%32.32%25.29%20.10% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept2.6151 of 5 stars$0.36-2.0%N/A-72.9%$2.63M$76.35M-0.05410News CoveragePositive NewsGap DownBTCYBiotricityN/A$0.38-12.8%N/A-66.0%$9.21M$12.06M-0.2740Gap DownAEMDAethlon Medical2.0924 of 5 stars$0.64-4.8%$7.00+1,002.4%-65.0%$8.87M$570,000.00-0.2310Analyst ForecastGap DownCHEKCheck-Cap0.2911 of 5 stars$1.50-2.0%N/A-41.8%$8.78MN/A-0.5080Analyst ForecastNews CoveragePositive NewsICUSeaStar Medical0.2025 of 5 stars$1.95-2.0%N/A-89.5%$8.70M$68,000.00-0.172POAIPredictive Oncology1.9506 of 5 stars$1.28-5.9%$3.00+134.4%-59.0%$8.53M$1.48M-0.4230NURONeuroMetrix0.9091 of 5 stars$4.01+1.0%N/A+35.0%$8.19M$3.77M-0.8720Positive NewsCUTRCutera1.4186 of 5 stars$0.40-12.7%$3.00+647.4%-82.7%$8.10M$155.21M-0.06460Analyst ForecastPositive NewsGap DownMHUAMeihua International Medical Technologies1.0025 of 5 stars$0.32-1.4%N/A-64.0%$7.97M$94.25M0.00620Positive NewsALURAllurion Technologies3.4113 of 5 stars$2.97-22.4%$71.88+2,323.3%-96.2%$7.69M$34.75M-6.18501STRRStar EquityN/A$2.19-1.4%N/A-53.1%$7.05M$45.78M-0.85460Positive News Related Companies and Tools Related Companies BTCY Alternatives AEMD Alternatives CHEK Alternatives ICU Alternatives POAI Alternatives NURO Alternatives CUTR Alternatives MHUA Alternatives ALUR Alternatives STRR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
